{"key":"cagrilintide","slug":"cagrilintide","name":"Cagrilintide","other_names":["Cagri","AM833","NN9838"],"kind":"single","area":{"slug":"metabolic","name":"Metabolic"},"classification":"Long-acting amylin analogue","standing":{"id":"phase-3","label":"Phase 3 trials","rank":4},"summary":"A long-acting analogue of the hormone amylin, studied alone and together with semaglutide in phase 3 trials in obesity.","cas_number":"1415456-99-3","molecular_formula":"C194H312N54O59S2","molecular_weight":"4409.01 g/mol","components":[],"has_article":false,"pubmed":{"papers":106,"in_humans":64,"clinical_trials":15},"retired":false,"updated_at":"2026-11-18T00:17:24.691Z","url":"https://pepts.wiki/compounds/cagrilintide","article":null,"evidence":{"query":"(\"Cagrilintide\"[tiab])","fetched_at":"2026-11-16T22:52:50.520Z","counts":{"rcts":15,"human":64,"total":106,"reviews":50,"clinicalTrials":15},"years":[{"year":2012,"count":0},{"year":2013,"count":0},{"year":2014,"count":0},{"year":2015,"count":0},{"year":2016,"count":0},{"year":2017,"count":0},{"year":2018,"count":0},{"year":2019,"count":0},{"year":2020,"count":0},{"year":2021,"count":8},{"year":2022,"count":6},{"year":2023,"count":5},{"year":2024,"count":14},{"year":2025,"count":30},{"year":2026,"count":51}],"top":[{"doi":"10.1136/bmj-2023-076410","url":"https://pubmed.ncbi.nlm.nih.gov/38286487/","kind":"review","pmid":"38286487","year":2024,"title":"Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis","venue":"BMJ (Clinical research ed.)","authors":"Yao H, Zhang A, Li D, et al."},{"doi":"10.1136/bmj-2026-372161","url":"https://pubmed.ncbi.nlm.nih.gov/42419792/","kind":"review","pmid":"42419792","year":2026,"title":"Comparative effects of drugs for adults with overweight or obesity: systematic review and network meta-analysis","venue":"BMJ (Clinical research ed.)","authors":"Nong K, Shi Q, Xie X, et al."},{"doi":"10.1056/NEJMoa2502081","url":"https://pubmed.ncbi.nlm.nih.gov/40544433/","kind":"rct","pmid":"40544433","year":2025,"title":"Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity","venue":"The New England journal of medicine","authors":"Garvey WT, Blüher M, Osorto Contreras CK, et al."},{"doi":"10.1056/NEJMoa2502082","url":"https://pubmed.ncbi.nlm.nih.gov/40544432/","kind":"rct","pmid":"40544432","year":2025,"title":"Cagrilintide-Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes","venue":"The New England journal of medicine","authors":"Davies MJ, Bajaj HS, Broholm C, et al."},{"doi":"10.1016/S0140-6736(23)01163-7","url":"https://pubmed.ncbi.nlm.nih.gov/37364590/","kind":"rct","pmid":"37364590","year":2023,"title":"Efficacy and safety of co-administered once-weekly cagrilintide 2·4 mg with once-weekly semaglutide 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial","venue":"Lancet (London, England)","authors":"Frias JP, Deenadayalan S, Erichsen L, et al."},{"doi":"10.1016/S0140-6736(21)01751-7","url":"https://pubmed.ncbi.nlm.nih.gov/34798060/","kind":"rct","pmid":"34798060","year":2021,"title":"Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial","venue":"Lancet (London, England)","authors":"Lau DCW, Erichsen L, Francisco AM, et al."},{"doi":"10.4103/ijem.ijem_45_24","url":"https://pubmed.ncbi.nlm.nih.gov/39676787/","kind":"review","pmid":"39676787","year":2024,"title":"Efficacy and Safety of Cagrilintide Alone and in Combination with Semaglutide (Cagrisema) as Anti-Obesity Medications: A Systematic Review and Meta-Analysis","venue":"Indian journal of endocrinology and metabolism","authors":"Dutta D, Nagendra L, Harish BG, et al."},{"doi":"10.1097/CRD.0000000000000513","url":"https://pubmed.ncbi.nlm.nih.gov/36883831/","kind":"study","pmid":"36883831","year":2024,"title":"Cagrilintide: A Long-Acting Amylin Analog for the Treatment of Obesity","venue":"Cardiology in review","authors":"D'Ascanio AM, Mullally JA, Frishman WH"}]},"library_version":"183:2026-11-17T11:05:42.386Z","attribution":"Data from Pepts.wiki (https://pepts.wiki), CC BY 4.0. Link back to the compound's page.","notice":"We are not doctors, and nothing on Pepts.wiki is medical advice or a recommendation to use anything. The wiki sets out what studies measured, as clearly and evenly as it can, so you can make better-informed decisions. Always consult a medical professional before acting on anything you read here."}